Systemic Cardiac Amyloidoses
Author(s) -
Claudio Rapezzi,
Giampaolo Merlini,
Candida Cristina Quarta,
Letizia Riva,
Simone Longhi,
Ornella Leone,
Fabrizio Salvi,
Paolo Ciliberti,
Francesca Pastorelli,
Elena Biagini,
Fabio Coccolo,
Robin M. T. Cooke,
Maria Letizia Bacchi Reggiani,
Diego Sangiorgi,
Alessandra Ferlini,
Michèle Cavo,
Elena Zamagni,
Maria Luisa Fonte,
Giovanni Palladini,
Francesco Salinaro,
Francesco Musca,
Laura Obici,
Angelo Branzi,
Stefano Perlini
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.843334
Subject(s) - medicine , intensive care medicine , cardiology
Most studies of amyloidotic cardiomyopathy consider as a single entity the 3 main systemic cardiac amyloidoses: acquired monoclonal immunoglobulin light-chain (AL); hereditary, mutated transthyretin-related (ATTRm); and wild-type transthyretin-related (ATTRwt). In this study, we compared the diagnostic/clinical profiles of these 3 types of systemic cardiac amyloidosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom